TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
MedPage Today’s Oct. 25, 2026, roundup collected comments from clinicians and researchers on dengue outbreaks, pregnancy exposure to dupilumab, an incorrect MS diagnosis and other medical developments. The remarks highlight issues and early findings, but the source does not provide enough detail to establish the scale or broader implications of the research discussed.
MedPage Today published a seven-quote weekly roundup on Oct. 25, 2026, featuring clinicians and researchers discussing dengue outbreaks in Florida, medication exposure during pregnancy, an incorrect multiple sclerosis diagnosis and several research findings. The comments flag developments across public health and patient care, but the roundup is a brief selection of remarks rather than a detailed account of the evidence behind each topic.
Adam Waickman, a researcher at SUNY Upstate Medical University, spoke about large dengue outbreaks in Florida and warned of possible further spread across the United States. “The cat is out of the bag,” he said. The item does not give case counts, locations beyond Florida, or a forecast for additional spread.
Christina Chambers of the University of California San Diego said it remains an open question whether early-life exposure to dupilumab, sold as Dupixent, could reduce a child’s later risk of atopic conditions. The roundup says data indicated that exposure during pregnancy appeared safe, but gives no study size, methods or follow-up period. Chambers described the longer-term question as “really interesting.”
Other comments addressed a range of clinical and research topics. Marisa McGinley of Cleveland Clinic said incorrect multiple sclerosis diagnoses do occur, while discussing actress Christina Applegate’s diagnosis. Lynn Sinitsky of an English hospital described an exceptionally rare case in which an infant initially treated for constipation was later found to have a second colon. The roundup also cited research on non-hormonal menopause drugs and sleep disturbances, a video tool for advance care planning among patients nearing kidney failure, and a small psilocybin trial in Parkinson’s disease.
Signals Across Public Health and Care
The roundup brings together issues with different kinds of relevance. Dengue spread is a public-health concern, while the dupilumab question bears on how clinicians and families understand medication exposure during pregnancy and children’s later health. The source, however, does not provide enough detail to assess either the outbreak’s trajectory or the strength of evidence about long-term effects.
The remaining items point to questions in diagnosis, symptom management and care planning. The reported menopause analysis concerns sleep, and the kidney-care research concerns recording patients’ preferences. The Parkinson’s trial is described as small and focused on biological markers; it should not be read as evidence that psilocybin improves symptoms or changes the disease course.
Popular right now
De'Longhi Stilosa Compact Manual Espresso Machine with Milk Frother
KitchenAid Artisan 5-Qt Tilt-Head Stand Mixer, Cardamom
Sony WH-1000XM4C Wireless Noise-Cancelling Headphones, Black
As an affiliate, we earn on qualifying purchases.
Seven Comments, Several Medical Topics
The original item is a recurring MedPage Today “What We Heard” roundup, not a single study or policy announcement. Its format collects quotations from reporting during the week, with brief descriptions of the subjects that prompted them. The publication date is Oct. 25, 2026.
The seven remarks cover dengue, dupilumab exposure, MS diagnosis, a rare infant intestinal condition, menopause-related sleep, advance care planning and a small Parkinson’s study. Those topics rely on different evidence and have different levels of certainty. The roundup’s short descriptions offer a snapshot of what its reporters heard, but do not replace the underlying studies, clinical records or public-health updates.
““This is good news for women.””
— JoAnn Manson, MD, MPH, DrPH, Harvard Medical School
Evidence and Scope Remain Limited
The roundup does not provide the underlying reports or enough information to independently assess their results. Dengue case totals, locations and projections are absent, so the extent and likelihood of further spread cannot be determined from this item alone.
For the dupilumab discussion, the article does not specify which pregnancy-exposure data were reviewed or how long children were followed. It also provides no study details for the menopause analysis or kidney-care tool. The Parkinson’s finding is explicitly described as coming from a small trial and involving inflammation and mitochondrial-stress markers; the roundup gives no participant count, results or evidence of clinical benefit. The rare infant case and Applegate’s diagnosis are mentioned without fuller clinical detail.
Full Reports Will Clarify Findings
The next useful step for readers is to consult the underlying studies and original reporting for methods, participant numbers, outcome measures and limitations. For dengue, public-health updates would be needed to track case counts and any documented spread beyond Florida. The roundup itself does not announce a new study release, deadline or follow-up event.
Until those details are available, the remarks are best understood as a weekly snapshot of issues being discussed by medical experts, not as standalone clinical guidance. The source does not say when additional results on the pregnancy-exposure question or the small Parkinson’s trial will be reported.
Key Questions
What is “The Cat Is Out of the Bag” about?
It is MedPage Today’s weekly collection of medical quotes, published Oct. 25, 2026. The seven comments cover several unrelated topics, including dengue, medication exposure and research.
What did Adam Waickman say about dengue?
Waickman said “The cat is out of the bag” while discussing large dengue outbreaks in Florida and warning of possible further spread across the United States. The roundup gives no case counts or specific forecast.
Does the roundup show that dupilumab exposure prevents atopic conditions?
No. Chambers said whether early-life exposure could lower a child’s later risk is an open question. The brief item says pregnancy exposure appeared safe in data it references but gives no study details or evidence of prevention.
What did the psilocybin study find?
The roundup says a small trial in people with Parkinson’s disease linked psilocybin with reduced markers of systemic inflammation and mitochondrial stress. It does not establish symptom improvement or disease modification.
Source: rss
